AI 본문요약

엑셀 다운로드 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

참고문헌 (96)

1. Harris JM, Chess RB. Effect of PEGylation on pharmaceuticals. Nat Rev Drug Discov 2003:2:215-21 

2. NEKTAR Therapeutics Co. Polyethylene glycol and derivatives for advanced PEGylation. Catalogue 2005-2006 Nektar Advanced PEGylation 

3. Veronese FM, Harris JM. Introduction and overview of peptide and protein pegylation. Adv Drug Deliv Rev 2002:54:453-6 

   상세보기

4. Bailon P, Palleroni A, Schaffer CA, Spence CL, Fung WJ, Porter JE et al. Rational Design of a Potent, Long-Lasting Form of Interferon: A 40 kDa Branched Polyethylene Glycol- Conjugated Interferon-2a for the Treatment of Hepatitis C. Bioconjug Chem 2001:12:195-202 

   상세보기

5. Ng EW, Shima DT, Calias P, Cunningham Jr. ET, Guyer DR, Adamis AP. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov 2006:5:123-32 

   상세보기

6. Cheng TL, Wu PY, Wu MF, Chern JW, Roffler SR. Accelerated clearance of polyethylene glycol-modified proteins by antipolyethylene glycol IgM. Bioconjug Chem 1999:10:520-8 

   상세보기

7. Dams ETM, Laverman P, Oyen WJG, Storm G, Scherphof GL, van Der Meer JW et al. Accelerated Blood Clearance and Altered Biodistribution of Repeated Injections of Sterically Stabilized Liposomes. J Pharmacol Exp Ther 2000:292:1071-9 

   상세보기

8. Caliceti P, Veronese FM. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. Adv Drug Deliv Rev 2003:55:1261-77 

   상세보기

9. Mahesh C. Polylactides/Glycolides-Excipients for Injectable Drug. Drug Del Tech 2002:2:21 

10. Johnson OL, Cleland JL, Lee HJ, Charnis M, Duenas E, Jaworowicz W et al. A month？long effect from a single injection of microencapsulated human growth hormone. Nat Med 1996:2:795-9 

    상세보기

11. Parveen S, Sahoo SK. Polymeric nanoparticles for cancer therapy. J Drug Targeting 2008:16:108-23 

    상세보기

12. Shenoy DB, Amiji MM. Poly(ethylene oxide)-modified poly (epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm 2005:293:261-70 

    상세보기

13. Devalapally H, Duan Z, Seiden MV, Amiji MM. Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer. Int J Cancer 2007:121:1830-80 

14. Vercruysse KP, Prestwich GD. Hyaluronate derivatives in drug delivery. Crit Rev Ther Drug Carrier Syst 1998:15:513-55 

15. Motokawa K, Hahn SK, Nakamura T, Miyamoto H, Shimoboji T. Selectively crosslinked hyaluronic acid hydrogels for. sustained release formulation of erythropoietin. J Biomed Mat Res 2006:78A:459-65 

    상세보기

16. Oh EJ, Kang SW, Kim BS, Jiang G, Cho IH, Hahn SK. Control of the molecular degradation of hyaluronic acid hydrogels for tissue augmentation. J Biomed Mater Res A 2008:86:685-93 

17. Luo Y, Prestwich GD. Synthesis and Selective Cytotoxicity of a Hyaluronic Acid-Antitumor Bioconjugate. Bioconj Chem 1999: 10:755-63 

    상세보기

18. Pusateri, AE., McCarthy SJ, Gregory KW, Harris RA, Cardenas L, McManus LT et al. Effect of a chitosan-based hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine. Journal of Trauma 2003:4:177-82 

19. Kean T, Roth S, Thanou M. Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency. J Control Release 2003:103:643-653 

    상세보기

20. Dodane V, Vivivalam VD. Pharmaceutical applications of chitosan. Pharm Sci Technol Today 1998:1:246-253 

    상세보기

21. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1998:15:1326-31 

    상세보기

22. Xu Y, Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm 2003:250:215-26 

    상세보기

23. Qi LF, Xu ZR, Li Y, Jiang X, Han XY. In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells. World J Gastroenterol 2005:11:5136-41 

24. Qi L, Xu Z, Chen M. In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles. Eur J Cancer 2007:43:184-93 

    상세보기

25. Sinha R, Kim GJ, Nie S, Shin DM. Nanotechnology in cancer therapeutics: Bioconjugated nanoparticles for drug delivery. Mol Cancer Ther 2006:5:1909-17 

    상세보기

26. Stinchcombe TE, Socinski MA, Walko CM, O'Neil BH, Collichio FA, Ivanova A et al. Goldberg RM, Lindley C, Claire Dees E..Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (abraxane(R)) on three treatment schedules in patients with solid tumors. Cancer Chemother Pharmacol 2007:60:759-66 

    상세보기

27. Brahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E et al. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res 2002:8:1038-44 

    상세보기

28. Dreis S, Rothweiler F, Michaelis M, Cinatl J Jr, Kreuter J, Langer K. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. Int J Pharm 2007:341:207-14 

    상세보기

29. Gabizon A, Martin F. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Drugs 1997:54:15-21 

30. Hussein MA, Wood L, Hsi E, et al. A phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients. Cancer 2002:95:2160-8 

    상세보기

31. Rifkin RM, Gregory SA, Mohrbacher A. Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a phase III multicenter randomized trial. Cancer 2006: 106:848-58 

    상세보기

32. Hussein MA, Wood L, Hsi E, Srkalovic G, Karam M, Elson P et al. A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients. Cancer 2002:95: 2160-8 

    상세보기

33. Vlugt-Wensink KD, Jiang X, Schotman G, Kruijtzer G, Vredenberg A, Chung JT et al. In vitro degradation behavior of microspheres base don cross-linked dextran. Biomacromol 2006: 7:2983-90 

    상세보기

34. Allen TM, Cullis PR. Drug Delivery Systems: Entering the Mainstream. Science 2004:303:1818-22 

    상세보기

35. Prescott JH, Lipka S, Samuel Baldwin, Sheppard Jr NF, Maloney JM, Coppeta J et al. Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device. Nat Biotechnol 2006:24:437-8 

    상세보기

36. Duros Technology Platform. http://www.durect.com/pdf/duros_ fact_sheet2001.pdf. Accessed Oct. 2008 

37. Staples M, Daniel K, Cima MJ, Langer R. Pharmaceutical Research 2006:23:847-863 

    상세보기

38. Brent G. http://www.hpl.hp.com/news/2008/jan-mar/skin_patch. html. Accessed Oct. 2008 

39. Kwon SY. In Vitro Evaluation of Transdermal Drug Delivery by a Micro-needle Patch. Controlled Release Society 31st Annual Meeting, TRANSACTIONS 2004, Abstract #115 

40. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discovery 2008:7:771-82 

    상세보기

41. Allen TM, Cullis PR. Drug Delivery Systems: Entering the Mainstream. Science 2004:303:1818-22 

    상세보기

42. Hashida M. Effect of particle size and charge on the disposition of lipid carriers after intratumoral injection into tissue-isolated tumors. Pharm Res 1998:15:128-32 

    상세보기

43. Parveen S, Sahoo SK. Polymeric nanoparticles for cancer therapy. Journal of Drug Targeting 2008:16:108-23 

    상세보기

44. Banks WA, Kastin AJ. Characterization of lectin-mediated brain uptake of HIV-1 GP120. J Neurosci Res 1998:54:522-9 

    상세보기

45. Fischer D, Kissel T. Histochemical characterization of primary capillary endothelial cells from porcine brains using monoclonal antibodies and fluorescein isothiocyanate-labelled lectins: Implications for drug delivery. Eur J Pharm Biopharm 2001:52:1-11 

    상세보기

46. Mo Y, Lim LY. Preparation and in vitro anticancer activity of WGA-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate. J Control Release 2005:107:30-42 

    상세보기

47. Jeong YI, Seo SJ, Park IK, Lee HC, Kang IC, Akaike T et al. Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gamma-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int J Pharm 2005:296:151-61 

    상세보기

48. Vasir JK, Labhasetwar V. Targeted drug delivery in cancer therapy. Technol Cancer Res Treat 2005:4:363-74 

    상세보기

49. Daniels TR, Delgado T, Helguera G, Penichet ML. The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells. Clin Immunol 2006:121:159-76 

    상세보기

50. Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 2006:121:144-58 

    상세보기

51. Xu Z, Gu W, Huang J, Sui H, Zhou Z, Yang Y et al. In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int J Pharm 2005:288:361-8 

    상세보기

52. Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 2002:54:675- 93 

    상세보기

53. Vasir JK, Labhasetwar V. Targeted drug delivery in cancer therapy. Technol Cancer Res Treat 2005:4:363-74 

    상세보기

54. Zhang Z, Huey LS, Feng SS. Folate-decorated poly(lactidecoglycolide)- vitamin E TPGS NPs for targeted drug delivery. Biomaterials 2007:28:1889-99 

    상세보기

55. Thorpe PE. Vascular targeting agents as cancer therapeutics. Clin Cancer Res 2004:10:415-27 

    상세보기

56. Weiner LM. Fully human therapeutic monoclonal antibodies. J Immunother 2006:29:1-9 

    상세보기

57. Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res 2006:66: 6732-40 

    상세보기

58. Burgstaller P, Jenne A, Blind M. 2002. Aptamers and aptazymes: Accelerating small molecule drug discovery. Curr Opin Drug Discov Devel 5:690-700 

    상세보기

59. Pestourie C, Tavitian B, Duconge F. 2005. Aptamers against extracellular targets for in vivo applications. Biochimie 87:921- 30 

    상세보기

60. Hicke BJ, Stephens AW. Escort aptamers: A delivery service for diagnosis and therapy. J Clin Invest 2000:106:923-8 

    상세보기

61. Farokhzad OC, Karp JM, Langer R. Nanoparticle-aptamer bioconjugates for cancer targeting. Expert Opin Drug Deliv 2006:3:311-24 

    상세보기

62. Moghimi SM, Hunter AC, Murray JC. Long- circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001:53:283-318 

    상세보기

63. Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today 2003:8:1112-20 

    상세보기

64. Cai W, Chen X. Nanoplatforms for targeted molecular imaging in living subjects. Small. 2007:3:1840-54 

    상세보기

65. Cai W, Chen X. Multimodality molecular imaging of tumor angiogenesis. J Nucl Med. 2008:49 Suppl 2:113S-28S 

    상세보기

66. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissues. Adv Drug Deliv Rev 2004:55:329-47 

    상세보기

67. Oh KT, Bronich TK, Kabanov AV. Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic block copolymers. J Control Release 2004:94:411-22 

    상세보기

68. Lukyanov AN, Gao ZG, Torchilin VP. Micelles from polyethylene glycol/phosphatidylethanolamine conjugates for tumor drug delivery. J Control Release 2003:91:97-102 

    상세보기

69. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science 2004:303:1818-1822 

    상세보기

70. Moghimi SM, Hunter AC, Murray JC. Long- circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001:53:283-31 

    상세보기

71. Biancco, A. Carbon nanotubes for the delivery of therapeutic molecules. Exp. Opin. Drug Deliv 2004:1:57-65 

    상세보기

72. Lopez CF, Nielsen SO, Moore PB, Klein ML. Understanding nature's design for a nanosyringe. Proc Natl Acad Sci USA 2004:101:4431-4 

73. Ali SS, Hardt JI, Quick KL, Kim-Han JS, Erlanger BF, Huang TT et al. A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties. Free Radical Biol Med 2004:37:1191-202 

    상세보기

74. Park KH, Chhowalla M, Iqbal Z, Sesti F. Single-walled carbon nanotubes are a new class of ion channel blockers. J Biol Chem 2003:278:50212-6 

    상세보기

75. Tomalia DA, Frechet JMJ. Discovery of dendrimers and dendritic polymers: a brief historical perspective. J Polym SciPart A: Polym Chem 2002:40:2719-28 

    상세보기

76. Haag R. Supramolecular drug-delivery systems based on polymeric core-shell architectures. Angew Chem Int Ed Engl 2004:43:278-82 

    상세보기

77. Rosa BA, Schengrund CL. Dendrimers and antivirals: a review. Curr Drug Targets Infect Disord 2005:5:247-54 

    상세보기

78. Derfus AM, Chen AA, Min DH, Ruoslahti E, Bhatia SN. Targeted quantum dot conjugates for siRNA delivery. Bioconjug Chem 2007:18:1391-6 

    상세보기

79. Bagalkot V, Zhang L, Levy-Nissenbaum E, Jon S, Kantoff PW, Langer R. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett 2007:7: 3065-70 

    상세보기

80. Hoshino A, Fujioka K, Oku T, Nakamura S, Suga M, Yamaguchi Y, et al. Quantum dots targeted to the assigned organelle in living cells. Microbiol Immunol 2004:48:985-94 

    상세보기

81. Howarth M, Takao K, Hayashi Y, Ting AY. Targeting quantum dots to surface proteins in living cells with biotin ligase. Proc Natl Acad Sci USA 2005:102:7583-8 

82. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004:22:969-76 

    상세보기

83. Derfus AM, Chan WCW, Bhatia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004:4:11-8 

    상세보기

84. Cho SJ, Maysinger D, Jain M, Roder B, Hackbarth S, Winnik FM. Long-term exposure to CdTe quantum dots causes functional impairments in live cells. Langmuir 2007:23:1974-80 

    상세보기

85. Green M, Howman E. Semiconductor quantum dots and free radical induced DNA nicking. Chem Commun (Camb) 2005: 121-3 

86. Choi AO, Cho SJ, Desbarats J, Lovric J, Maysinger D. Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells. J Nanobiotechnol 2007:5:1-5 

    상세보기

87. Lovric J, Cho SJ, Winnik FM, Maysinger D. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem Biol 2005:12:1227-34 

    상세보기

88. Zhu MQ, Han JJ, Li AD. CdSe/CdS/SiO2 core/shell/shell nanoparticles. J Nanosci Nanotechnol 2007:7:2343-8 

    상세보기

89. Kim D, Park S, Lee JH, Jeong YY, Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc 2007: 129:7661-5 

    상세보기

90. Edwards EW, Chanana M, Wabg DY, Mohwald H. Stimuliresponsive transport of nanoparticles across water-oil interfaces. Angew Chem Int Ed Engl 2008:47:320-3 

    상세보기

91. Esenturk EN, Walker AR Surface-enhanced Raman scattering spectroscopy via gold nanostars. J Raman Spectroscopy 2008: Sep:Epub ahead of print 

92. Schellenberger EA, Reynolds F, Weissleder R, Josephson L. Surface-functionalized nanoparticle library yields probes for apoptotic cells. Chem Bio Chem 2004:5:275-9 

    상세보기

93. Jaffer FA, Weissleder R. Seeing within―molecular imaging of the cardiovascular system. Circ Res 2004:94:433-45 

    상세보기

94. Perez, JM, Josephson L, Weissleder R. Use of magnetic nanoparticles as nanosensors to probe for molecular interactions. Chem Bio Chem 2004:5:261-4 

    상세보기

95. Gilad AA, Walczak P, McMahon MT, Na HB, Lee JH, An K et al. MR Tracking of Transplanted Cells With 'Positive Contrast' Using Manganese Oxide Nanoparticles. Magnetic Resonance in Medicine 2008:60:1-7 

    상세보기

96. Cheon J, Lee JH. Synergistically Integrated Nanoparticles as Multimodal Probes for Nanobiotechnology. Acc Chem Res 2008 Aug:Epub ahead of print 

저자의 다른 논문 :

윤혜원 (4) 강건욱 (17) 정준기 (232) 이동수 (228)